Young James Emmett bought TLSI
January 27, 2025 · Form 4 insider transaction
Young James Emmett bought 12,500 shares of TriSalus Life Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$0.00
Total value
N/A
InsiderYoung James Emmett
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 27, 2025
Filing dateJanuary 29, 2025
Shares owned after21,726
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.